Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Tetrachlorodecaoxide (TCDO) Drops in Chronic Wound Healing
Sponsor: Fazeelat Bibi
Summary
This is a single-center, randomized controlled trial evaluating the effectiveness of topical tetrachlorodecaoxide (TCDO) solution in enhancing chronic wound healing. The study will compare standard wound care with and without the addition of topical TCDO drops. Eligible adult participants with chronic wounds of more than six weeks' duration will be randomly assigned to either the intervention or control group. The trial aims to assess the rate of wound healing, time to 50% wound closure, pain reduction measured by the Visual Analog Scale (VAS), and cost-effectiveness.
Official title: Efficacy of Tetrachlorodecaoxide (TCDO) Drops in Chronic Wound Healing: Insights From a Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
66
Start Date
2025-08-30
Completion Date
2026-08-30
Last Updated
2025-08-05
Healthy Volunteers
No
Conditions
Interventions
Topical Tetrachlorodecaoxide (TCDO/Oxoferin)
Topical Tetrachlorodecaoxide (TCDO), a solution with antimicrobial and oxygen-releasing properties, will be applied once daily to the wound bed for 21 consecutive days or until satisfactory healing.
Standard Wound Care
Standard wound care includes saline irrigation, wound debridement, antibiotic administration as necessary, and sterile dressing. Provided to all participants.
Locations (1)
Khyber Teaching Hospital, MTI KTH Peshawar
Peshawar, Khyber Pakhtunkhwa, Pakistan